close this window

Home / Research issues / Global Forum initiatives / Public-private partnerships

aAReset sizeExport PDFPrintSendBookmarkText-only

Public-private partnerships


While neither the public nor the private sector alone can eliminate health inequities, together they can make a synergistic contribution. In the last few years, product development partnerships (PDPs), a form of public-private partnerships (PPPs), have gained growing popularity as mechanisms for increasing access by poor populations to essential drugs. As a result, PDPs have established an expanded pipeline of candidate drugs and vaccines for clinical trials.

The scale of investments now needed to ensure that the best candidates go forward into clinical trials exceeds the funding capacity of any one donor in the public or philanthropic sectors.

What the Global Forum does

The Global Forum created the Initiative on Public-Private Partnerships for Health (IPPPH), which grew out of early Global Forum efforts to enhance health equity and recognition of the need for a more systematic response to catalysing effective public-private collaboration.

Indeed, the Global Forum helped broker and facilitate the founding of some of the public-private partnerships, such as Medecines for Malaria Venture.

The Global Forum continues to contribute to the debate about the future role of PDPs, calling for closing the gap between the health of the poorest and those who are better off through a collective (funding) effort. It has supported the continuation of a PPP database, originally developed by IPPPH and now transferred to INNOGEN in the UK where it will be maintained as an on-line resource


Further reading:

IPPPH studies (Under construction)